{"id":90317,"date":"2019-05-06T10:46:08","date_gmt":"2019-05-06T17:46:08","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/05\/algorithms-help-spot-cancer-lottery-winners-in-new-fred-hutch-study"},"modified":"2019-05-06T10:46:08","modified_gmt":"2019-05-06T17:46:08","slug":"algorithms-help-spot-cancer-lottery-winners-in-new-fred-hutch-study","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/05\/algorithms-help-spot-cancer-lottery-winners-in-new-fred-hutch-study","title":{"rendered":"Algorithms help spot cancer \u2018lottery winners\u2019 in new Fred Hutch study"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/algorithms-help-spot-cancer-lottery-winners-in-new-fred-hutch-study2.jpg\"><\/a><\/p>\n<p>For most patients, a diagnosis of stage 4 non-small cell lung cancer comes with a dire prognosis. But for patients with specific mutations that cause the disease, there are potentially life-saving therapies.<\/p>\n<p>The problem is that these mutations, known as ALK and EGFR, are not always identified in patients \u2014 meaning they never get the treatment.<\/p>\n<p>A <a href=\"https:\/\/ascopubs.org\/doi\/abs\/10.1200\/CCI.18.00098?journalCode=cci\">new study<\/a> from the Fred Hutchinson Cancer Research Center in Seattle used machine learning to find these needle-in-a-haystack patients. The idea was to leverage cancer databases to see if patients were being tested for the mutations and receiving these personalized treatments.<\/p>\n<p><a href=\"https:\/\/www.geekwire.com\/2019\/algorithms-helps-spot-cancer-lottery-winners-new-fred-hutch-study\/\" target=\"_blank\" rel=\"noopener noreferrer\"><\/p>\n<div style=\"clear:both;\">Read more<\/div>\n<p><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For most patients, a diagnosis of stage 4 non-small cell lung cancer comes with a dire prognosis. But for patients with specific mutations that cause the disease, there are potentially life-saving therapies. The problem is that these mutations, known as ALK and EGFR, are not always identified in patients \u2014 meaning they never get the [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,41,6],"tags":[],"class_list":["post-90317","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-information-science","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/90317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=90317"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/90317\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=90317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=90317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=90317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}